SHENEQUA FISHER: Open Payments
NPI 1760153043 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 31 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $441 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $473 |
| Dynavax Technologies Corporation | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Dexcom, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $56 |
| ABBVIE INC. | 2 | $51 |
| Exact Sciences Corporation | 2 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| UCB, Inc. | 1 | $20 |
Products named: Ozempic, Wegovy, Heplisav-B, Dexcom G6 Transmitter, NURTEC ODT, VRAYLAR, Cologuard Collection Kit, BREZTRI.
Industry payments across FL — which companies pay providers there.
